Literature DB >> 30575911

Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.

B Yan1, W Zhang, X-W Mao, L-Y Jiang.   

Abstract

OBJECTIVE: This study aimed to assess the association of circular RNA (circRNA) ciRS-7 expression with clinicopathological characteristics and prognosis of non-small cell lung cancer (NSCLC) patients, and to investigate its effect on cells proliferation as well as apoptosis in NSCLC. PATIENTS AND METHODS: 132 patients with primary NSCLC who received surgical resection were recruited in this retrospective study. All patients' tumor tissue and paired adjacent tissue were collected for circRNA ciRS-7 expression detection by RT-qPCR. Disease-free survival (DFS) and overall survival (OS) were calculated. CCK-8 and Annexin-V/propidium iodide (AV/PI) assays were performed to detect cells proliferation and apoptosis in A549 cells after circRNA ciRS-7 inhibition plasmid transfection.
RESULTS: CircRNA ciRS-7 expression in tumor tissue was elevated compared to paired adjacent tissue, and positively correlated with tumor size, lymph node metastasis and tumor node metastasis (TNM) stages. K-M curves illustrated that circRNA ciRS-7 high expression was correlated with both shorter DFS and OS, and multivariate Cox's proportional hazards regression analysis showed that circRNA ciRS-7 high expression was an independent factor for predicting unfavorable DFS and OS. Cells methods revealed that circRNA ciRS-7 expression was elevated in NSCLC cell lines (A549, PC9, NCI-H1299 and NCI-H1650) compared to normal lung epithelial cells (DEAS-2B), and the inhibition of circRNA ciRS-7 expression reduced cells proliferation and promoted cells apoptosis in A549 cells.
CONCLUSIONS: CircRNA ciRS-7 overexpression is associated with advanced disease and poor prognosis in NSCLC patients, and the down-regulation of circRNA ciRS-7 inhibits tumor cells proliferation as well as improves cells apoptosis.

Entities:  

Year:  2018        PMID: 30575911     DOI: 10.26355/eurrev_201812_16636

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  18 in total

1.  Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma.

Authors:  Dingyang Li; Zhe Tang; Zhiqiang Gao; Pengcheng Shen; Zhaochen Liu; Xiaowei Dang
Journal:  Mol Cell Biol       Date:  2020-07-14       Impact factor: 4.272

2.  Biomarker potentials of miRNA-associated circRNAs in breast cancer (MCF-7) cells: an in vitro and in silico study.

Authors:  Sema Misir; Ceylan Hepokur; Yuksel Aliyazicioglu; Francisco J Enguita
Journal:  Mol Biol Rep       Date:  2021-03-28       Impact factor: 2.316

3.  ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis.

Authors:  Jun-Ya Han; Si Guo; Na Wei; Rui Xue; Wencai Li; Gang Dong; Jianhua Li; Xiangyu Tian; Chao Chen; Sen Qiu; Tong Wang; Qiankun Xiao; Chenguang Liu; Jingjing Xu; Kui-Sheng Chen
Journal:  Biomed Res Int       Date:  2020-06-21       Impact factor: 3.411

4.  Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress ovarian cancer progression.

Authors:  He Chen; Min Mao; Jing Jiang; Daling Zhu; Peiling Li
Journal:  Onco Targets Ther       Date:  2019-05-17       Impact factor: 4.147

5.  Integrated analysis of circular RNA-associated ceRNA network in cervical cancer: Observational Study.

Authors:  Jun Gong; Hui Jiang; Chang Shu; Mei-Qin Hu; Yan Huang; Qin Liu; Rong-Feng Li; Yin-Zhi Wei
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

6.  Prognostic role of dysregulated circRNAs in patients with non-small cell lung cancer: a meta-analysis.

Authors:  Quanwa Bao; Feng Li; Houzhen Zheng; Shaobo Chen; Xiao Song
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

7.  Circular RNA ATXN7 promotes the development of gastric cancer through sponging miR-4319 and regulating ENTPD4.

Authors:  Zhen Zhang; Honglei Wu; Zhaosheng Chen; Guangchun Li; Bin Liu
Journal:  Cancer Cell Int       Date:  2020-01-23       Impact factor: 5.722

Review 8.  Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives.

Authors:  Huan-Huan Chen; Tie-Ning Zhang; Qi-Jun Wu; Xin-Mei Huang; Yu-Hong Zhao
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

9.  Circular RNA hsa_circ_0072309 inhibits non-small cell lung cancer progression by sponging miR-580-3p.

Authors:  Wenguang Pang; Fengliu Huang; Xin Zhang; Min Ye; Yanming Huang; Xiufang Huang; Jingzhuo Pang; Chengjie Cai; Zheng Wang
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

Review 10.  Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?

Authors:  Lihui Lin; Gaoshi Zhou; Peng Chen; Ying Wang; Jing Han; Minhu Chen; Yao He; Shenghong Zhang
Journal:  Cell Death Dis       Date:  2020-06-15       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.